AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norfray, J. F.
Right arrow Articles by Miller, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norfray, J. F.
Right arrow Articles by Miller, R. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 173, 119-125, Copyright © 1999 by American Roentgen Ray Society

ARTICLES

Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors

JF Norfray, T Tomita, SE Byrd, BD Ross, PA Berger and RS Miller
Chicago Northside MRI Center, IL 60657, USA.

OBJECTIVE: We undertook this study to determine if single-voxel proton (hydrogen) MR spectroscopy could have clinical impact on the management of pediatric brain tumors when MR findings were indeterminate. SUBJECTS AND METHODS: Eleven children (mean age, 9 years) being examined for brain tumors underwent MR imaging that revealed indeterminate criteria of enhancement, mass effect, and prolonged T1 and T2 signal. MR spectroscopy was then used to distinguish radiation necrosis from tumor in one patient, differentiate residual tumor from scarring in two patients, document early treatment response in three patients, and discriminate benign from malignant masses in five patients. RESULTS: In 10 of the 11 patients, spectra were successfully acquired. Based on the chemical analysis of the indeterminate area shown on MR imaging, clinical impact was achieved in these 10 patients. Clinical impact included treatment modification in five patients, follow-up studies replacing further treatment in three patients, and tumor characterization in the remaining two patients. Confirmation was by histology in four patients and by follow-up MR imaging and MR spectroscopy for up to 30 months in the remaining six patients. CONCLUSION: When MR imaging is indeterminate in evaluating pediatric brain tumors, MR spectroscopy can provide objective neurochemical information, thereby altering treatment.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
S.B. Thakur, S. Karimi, I.J. Dunkel, J.A. Koutcher, and W. Huang
Longitudinal MR spectroscopic imaging of pediatric diffuse pontine tumors to assess tumor aggression and progression.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 806 - 809.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
A. A. Tzika, M. K. Zarifi, L. Goumnerova, L. G. Astrakas, D. Zurakowski, T. Young-Poussaint, D. C. Anthony, R. M. Scott, and P. McL. Black
Neuroimaging in Pediatric Brain Tumors: Gd-DTPA-enhanced, Hemodynamic, and Diffusion MR Imaging Compared with MR Spectroscopic Imaging
AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 322 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
M. Castillo, J. K. Smith, and L. Kwock
Correlation of Myo-inositol Levels and Grading of Cerebral Astrocytomas
AJNR Am. J. Neuroradiol., October 1, 2000; 21(9): 1645 - 1649.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
Y. Mardor, O. Kaplan, M. Sterin, J. Ruiz-Cabello, E. Ash, Y. Roth, I. Ringel, and J. S. Cohen
Noninvasive Real-Time Monitoring of Intracellular Cancer Cell Metabolism and Response to Lonidamine Treatment Using Diffusion Weighted Proton Magnetic Resonance Spectroscopy
Cancer Res., September 1, 2000; 60(18): 5179 - 5186.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Roentgen Ray Society.